Published by Misasa Medical Center, Okayama University Medical School
Published by Misasa Medical Center, Okayama University Medical School

<Formerly known as>
岡大三朝分院研究報告 (63号-72号) 環境病態研報告 (57号-62号)
岡山大学温泉研究所報告 (5号-56号) 放射能泉研究所報告 (1号-4号)

<Availability>
Some items are not available because of decision by its author or publisher.

Candida-specif ic IgG(4) ant ibodies and bronchial asthma

谷崎 勝朗 岡山大学医学部附属病院三朝分院内科
貴谷 光 岡山大学医学部附属病院三朝分院内科
岡崎 守宏 岡山大学医学部附属病院三朝分院内科
御舩 尚志 岡山大学医学部附属病院三朝分院内科
光延 文裕 岡山大学医学部附属病院三朝分院内科
高取 明正 岡山大学医学部附属病院三朝分院産科婦人科
奥田 博之 岡山大学医学部附属病院三朝分院産科婦人科
原田 英雄 岡山大学医学部附属環境病態研究施設成人病学分野
抄録
Serum levels of Candida-specific IgG(4) antibodies were examined in 66 patients with bronchial asthma, relating to patient age and asthma severity. 1. The levels of Candida-specific IgG(4) antibodies were the highest in patients with 60+years of age, compared to the levels in cases with 0-39 and 40-59 years of age. 2. In cases with 40-59 years of age, the levels of Candida-specific IgG(4) were significantly higher in cases with long-term steroid therapy (severe intractable asthma) than in cases without steroid regimen. The results suggest that increased levels of Candida-specific IgG(4) were observed in relation to patient age and asthma severity.
キーワード
Candida (カンジダ)
Sepcific IgG(4) (特異的IgG(4))
Bronchial asthma (気管支喘息)
Aging (加齢)
Asthma severity (喘息重症度)
ISSN
0913-3771
NCID
AN10084718